0001406666-23-000041.txt : 20231030
0001406666-23-000041.hdr.sgml : 20231030
20231030170228
ACCESSION NUMBER: 0001406666-23-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231027
FILED AS OF DATE: 20231030
DATE AS OF CHANGE: 20231030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collins John Matthew
CENTRAL INDEX KEY: 0001887165
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34674
FILM NUMBER: 231361204
MAIL ADDRESS:
STREET 1: C/O CALIX, INC.
STREET 2: 2777 ORCHARD PARKWAY
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CALIX, INC
CENTRAL INDEX KEY: 0001406666
STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899]
IRS NUMBER: 680438710
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2777 ORCHARD PARKWAY
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 408-514-3000
MAIL ADDRESS:
STREET 1: 2777 ORCHARD PARKWAY
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: CALIX NETWORKS INC
DATE OF NAME CHANGE: 20070713
4
1
wk-form4_1698699738.xml
FORM 4
X0508
4
2023-10-27
0
0001406666
CALIX, INC
(CALX)
0001887165
Collins John Matthew
C/O CALIX, INC.
2777 ORCHARD PARKWAY
SAN JOSE
CA
95134
0
1
0
0
Chief Commercial Ops Officer
0
Common Stock
2023-10-27
4
M
0
15000
6.95
A
15000
D
Common Stock
2023-10-27
4
M
0
15000
8.03
A
30000
D
Common Stock
2023-10-27
4
M
0
30000
9.16
A
60000
D
Common Stock
2023-10-27
4
S
0
60000
33.14
D
0
D
Stock Option (right to buy)
6.95
2023-10-27
4
M
0
15000
0
D
2027-08-01
Common Stock
15000
20171
D
Stock Option (right to buy)
8.03
2023-10-27
4
M
0
15000
0
D
2029-02-14
Common Stock
15000
25000
D
Stock Option (right to buy)
9.16
2023-10-27
4
M
0
30000
0
D
2030-01-31
Common Stock
30000
165000
D
Shares sold between $32.39 and $34.12 per share at a weighted average price of $33.14. The reporting person will provide full information regarding the number of shares sold at each sale price upon request.
80,000 of the shares subject to the option grant were fully vested and exercisable on July 17, 2021.
45,000 of the shares subject to the option grant were fully vested and exercisable on February 14, 2023.
175,000 of the shares subject to the option grant were fully vested and exercisable on July 31, 2023.
/s/ Tom Gemetti as Attorney-in-Fact for John Matthew Collins
2023-10-30